Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
HIKAL | NSE
12.88
8.76%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
01/04/2026
159.96
155.00
162.00
150.22
Hikal Limited together with its subsidiaries manufactures and sells various chemical intermediates specialty chemicals and active pharma ingredients to pharmaceutical animal healthcare biotech crop protection and specialty chemicals companies. It operates through two segments Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research custom synthesis and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives as well as additives for leather paint coatings paper water treatment personal care building materials and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai India.
View LessStrength based on increasing price with high volume
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
85.5%1 month
62.1%3 months
50.7%6 months
44.6%69.03
16.75
3.83
0.69
0.33
20.06
3.02
-
2.73B
19.72B
211.65M
0.32
6.44
-26.80
4.80
6.00
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
30.55
Range1M
48.75
Range3M
82.85
Rel. volume
1.01
Price X volume
71.02M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Unichem Laboratories Limited | UNICHEMLAB | Drug Manufacturers-Specialty & Generic | 298.2 | 21.07B | 1.62% | n/a | 10.48% |
| Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 37.2 | 20.55B | 10.45% | 37.53 | 3.42% |
| Panacea Biotec Limited | PANACEABIO | Biotechnology | 325.3 | 20.30B | 9.88% | n/a | 2.49% |
| SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 459.1 | 19.89B | 7.88% | n/a | 107.90% |
| Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 76.49 | 19.71B | 7.88% | 12.29 | 0.42% |
| Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 187.08 | 17.24B | 14.07% | 42.22 | 60.54% |
| Windlas Biotech Limited | WINDLAS | Drug Manufacturers-Specialty & Generic | 767.65 | 16.10B | 4.19% | 35.85 | 0.81% |
| Amrutanjan Health Care Limited | AMRUTANJAN | Drug Manufacturers-Specialty & Generic | 499.5 | 14.45B | 1.19% | 52.36 | 0.60% |
| Lincoln Pharmaceuticals Ltd | LINCOLN | Drug Manufacturers-Specialty & Generic | 594.85 | 11.91B | 5.29% | 13.55 | 0.18% |
| Hester Biosciences Limited | HESTERBIO | Drug Manufacturers-Specialty & Generic | 1365.6 | 11.62B | 8.46% | 104.15 | 83.75% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 101.34 | 14.93B | 12.25% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 231.11 | 13.55B | 4.36% | 30.54 | 80.30% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 189.42 | 6.76B | 0.17% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 151.06 | 4.88B | 9.69% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 57.49 | 1.59B | 4.99% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 83.8 | 1.22B | 13.34% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 65.89 | 734.59M | 4.50% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 22.89 | 397.37M | 3.95% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 6.92 | 151.62M | 14.38% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 20.06 | 24.85 | Par |
| Ent. to Revenue | 3.02 | 11.40 | Cheaper |
| PE Ratio | 69.03 | 51.36 | Expensive |
| Price to Book | 3.83 | 6.83 | Cheaper |
| Dividend Yield | 0.32 | 0.52 | Poor |
| Std. Deviation (3M) | 50.74 | 42.17 | Riskier |
| Debt to Equity | 0.69 | 0.35 | Expensive |
| Debt to Assets | 0.33 | 0.17 | Expensive |
| Market Cap | 19.72B | 290.82B | Emerging |